Noma

Summary

Noma (MONDO:0017124) is a disease. A subtype of ulcerative stomatitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Prevalence: Unknown (Worldwide)

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	noma
Mondo ID	MONDO:0017124
EFO	EFO:1001063
MeSH	D009625
Orphanet	2700
DOID	DOID:9672
ICD-10-CM	A69.0
ICD-11	340823130
NCIT	C34852
SNOMED CT	18116006
UMLS	C0028271
MedGen	10366
GARD	0004001
MedDRA	10029502
Is cancer (heuristic)	no

Also known as: cancrum oris · gangrenous stomatitis · noma neonatorum · oral gangrene · oro-facial gangrene · oro-facial noma

Disease family

This is a subtype of ulcerative stomatitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by developmental or physiological process › inflammatory disease › mucositis › stomatitis › ulcerative stomatitis › noma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.